Apollo Commercial sells its $9B CRE loan portfolio to Athene, boosting cash and book value support while keeping its $0.25 ...

Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that it has commenced an exchange offer ...

Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled ...

Lexicon Pharmaceuticals (LXRX) has priced its public offering of 32M shares of its common stock, par value $0.001, at $1.30 per share to raise $41.6M. The firm has granted the underwriters a 30-day ...

In addition to the shares being sold in the underwritten public offering, Lexicon has agreed to sell, in a concurrent private placement for expected aggregate gross proceeds of approximately $41.1 ...

Spire Inc. (NYSE: SR) (the "Company") announced today that it has delivered notice to holders of the Company's 5.90% Series A ...

A one-time accounting change will boost the bank's ability to spend on marketing. Traders flinched at the change; analysts called it a buying opportunity.

IRVINE, CA / ACCESS Newswire / January 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the ...

Applied stockholders who have previously tendered their shares do not need to re-tender their shares or take any other action ...

The offering was made by the Company pursuant to a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission (the “SEC”) on December 1, 2025 and was declared ...

The MarketWatch News Department was not involved in the creation of this content.-- The Company reported another sequential quarter of higher net income and improved asset quality ...

GGT.PR.E and GGT.PR.G preferreds yield 6%+ below par with A3 ratings, low leverage, and qualified dividends. Read the full ...